Bioregenx BRGX
OTC BRGX
$0.01 +0.00 (+0.00%)
At close: Sep 21, 2026 · 4:00 PM EDT

Bioregenx (BRGX) Cash & Equivalents (2021 - 2026)

Bioregenx (BRGX) posted Cash & Equivalents of $45806.0 for Q1 2026, down 33.98% on a QoQ basis from $69383.0 in Q4 2025, and down 45.22% year-over-year from $83625.0 in Q1 2025.

Analysis

Bioregenx (BRGX) Cash & Equivalents (2021 - 2026) Analysis & Trends

Bioregenx has reported Cash & Equivalents for 6 years, with the latest figure at $45806.0 in Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 45.22% year-over-year to $45806.0 in Q1 2026; TTM through Mar 2026 was $45806.0, a 45.22% decrease from a year earlier, with the FY2025 full-year figure at $69383.0, up 18.8% from the prior year.
  • Cash & Equivalents was $45806.0 for Q1 2026 at Bioregenx, down from $69383.0 in the prior quarter.
  • The five-year high for Cash & Equivalents was $125402.0 in Q4 2023, with the low at $676.0 in Q4 2022.
  • Average Cash & Equivalents over 5 years is $48412.9, with a median of $46947.0 recorded in 2025.
  • The sharpest annual moves came in 2022 and 2023: Cash & Equivalents tumbled 97.22% in 2022, then jumped 18450.59% in 2023.
  • Over 5 years, Cash & Equivalents stood at $676.0 in 2022, then surged by 18450.59% to $125402.0 in 2023, then tumbled by 53.43% to $58404.0 in 2024, then increased by 18.8% to $69383.0 in 2025, then sank by 33.98% to $45806.0 in 2026.
  • The last three Cash & Equivalents figures came in at $45806.0 (Q1 2026), $69383.0 (Q4 2025), and $46947.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Abbott Laboratories 179.49 Bn 174.54 Bn 7.27 Bn 5.10 Bn
2 Intuitive Surgical 142.30 Bn 137.21 Bn 1.96 Bn 2.76 Bn
3 Medtronic 116.24 Bn 108.04 Bn 6.34 Bn 1.69 Bn
4 Stryker 105.51 Bn 102.03 Bn 4.50 Bn 3.39 Bn
5 Boston Scientific 65.13 Bn 64.83 Bn 3.85 Bn 539.00 Mn
6 Edwards Lifesciences 51.20 Bn 47.05 Bn 1.35 Bn 2.91 Bn
7 Dexcom 33.79 Bn 31.84 Bn 830.00 Mn 1.11 Bn
8 Resmed 32.01 Bn 30.54 Bn 861.22 Mn 1.47 Bn
9 Alcon 31.98 Bn 30.52 Bn 1.68 Bn 1.36 Bn
10 Bioregenx 9.72 Mn 9.67 Mn 348,288.00 45,806.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 45,806.00
Dec 31, 2025 69,383.00
Sep 30, 2025 46,947.00
Jun 30, 2025 46,456.00
Mar 31, 2025 83,625.00
Dec 31, 2024 58,404.00
Sep 30, 2024 70,081.00
Jun 30, 2024 57,395.00
Mar 31, 2024 114,158.00
Dec 31, 2023 125,402.00
Sep 30, 2023 758.00
Dec 31, 2022 676.00
Sep 30, 2022 1,541.00
Jun 30, 2022 2,123.00
Mar 31, 2022 3,438.00
Dec 31, 2021 24,358.00
API Access

Bioregenx Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BRGX&period=max&api_key=YOUR_API_KEY